Time course observation of thyroid proliferative lesions and serum TSH levels in rats treated with thiourea after DHPN initiation.
Time course changes in serum TSH and quantitative data for thyroid proliferative lesions in male F344 rats administered N-bis(2-hydroxypropyl)nitrosamine (DHPN: 2000 mg/kg body weight, single s.c. injection) followed by 0.1% thiourea (TU), were assessed at weeks 1, 2, 4, 8, 12 and 16 of treatment. The serum T4 level in the TU group was markedly decreased at week 1 and remained significantly lowered throughout the experiment. Serum TSH levels, in contrast, were elevated up to a peak at around week 4 with a return to the normal range at week 12. Thyroid weights in the TU group were increased significantly in a treatment period-dependent manner. Histopathologically, marked hypertrophy of thyroid follicular cells occurred at the early stage of TU treatment. Proliferative lesions, such as hyperplasia and adenomas, occurred from weeks 2 and 4, respectively, and increased with the later treatment period. The cell proliferative activity of follicular cells, assessed by BrdU incorporation, was high until week 2, but then returned to normal. The initially appearing hyperplasias and adenomas were characterized by marked proliferation but this also greatly decreased at later stages when TSH was no longer elevated. The results of our study thus suggest that a high serum TSH level plays an important role in the early phase of thyroid tumorigenesis and 8 weeks treatment with test substances is sufficient for detection of thyroid tumor promoter potential in two-stage thyroid carcinogenesis models.
Shimo
T
T
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan.
Mitsumori
K
K
Onodera
H
H
Yasuhara
K
K
Takahashi
M
M
Takahashi
M
M
Ueno
Y
Y
Hayashi
Y
Y
D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000008:administration & dosage; D002455:Cell Division / Q000187:drug effects; D004334:Drug Administration Schedule; D006965:Hyperplasia / Q000139:chemically induced; D008297:Male; D009602:Nitrosamines / Q000008:administration & dosage*; D009929:Organ Size / Q000187:drug effects; D010902:Pituitary Gland / Q000033:anatomy & histology; D051381:Rats; D011916:Rats, Inbred F344; D013890:Thiourea / Q000008:administration & dosage*; D013959:Thyroid Diseases / Q000139:chemically induced*; D013961:Thyroid Gland / Q000187:drug effects* / Q000473:pathology; D013972:Thyrotropin / Q000097:blood*; D013997:Time Factors
D002273:Carcinogens; D009602:Nitrosamines; C012457:diisopropanolnitrosamine; D013972:Thyrotropin; D013890:Thiourea